Skip to content

Conducting Airways in Lung Fibrosis (VACFI)

Conducting Airways in Lung Fibrosis

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT01777373
Acronym
VACFI
Enrollment
141
Registered
2013-01-28
Start date
2012-08-31
Completion date
2015-02-28
Last updated
2015-04-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Idiopathic Pulmonary Fibrosis

Keywords

conducting airway, bronchiolization

Brief summary

The purpose of this study is to determine whether extension of the conducting airways into the distal lung, or bronchiolization, occurs early in the course of Idiopathic Pulmonary Fibrosis, a disease wherein normal lung structures are destroyed and replaced by non-functional scar tissue.

Detailed description

Diffuse Interstitial Pneumonias are a heterogeneous group of chronic respiratory diseases. Idiopathic Pulmonary Fibrosis, one of such diseases, is characterized by lesions of the conducting airways including extension of bronchioles towards the distal lung, or bronchiolization of the distal lung. Such lesions are traditionally referred to as traction bronchiectasis although no evidence supports a cause-and-effect relationship between alveolar fibrosis and airway lesions. Another feature of IPF is chronic, invalidating dry cough. Our hypothesis is that IPF is characterized by early increases in the volume of conducting airways, that such changes correlate with cough, and that airway changes are in direct relation with airway fibrosis. The primary aim of this study is to demonstrate increased anatomical dead space (VD), a surrogate for conducting airway volume, in patients with moderate (or early) IPF, in comparison with subjects without any respiratory disease (non-DIP controls). The secondary aims are : To show that VD is increased in patients with IPF in comparison with patients with other DIPs (DIP controls), to show that in patients with IPF increased VD does not correlate with indices of alveolar fibrosis, and to show associations between increased VD and cough and other respiratory symptoms in patients with IPF.

Interventions

None listed

Sponsors

Assistance Publique - Hôpitaux de Paris
Lead SponsorOTHER

Study design

Observational model
CASE_CONTROL
Time perspective
CROSS_SECTIONAL

Eligibility

Sex/Gender
ALL
Age
18 Years to 85 Years
Healthy volunteers
Yes

Inclusion criteria

IPF : INCLUSION CRITERIA 1. Age 18-85 years 2. IPF diagnosed according to ATS/ERS/JRS/ALAT criteria 3. Patient gave informed consent NON INCLUSION CRITERIA 1. Presence of respiratory comorbidities : Asthma, COPD, bronchiectasis, emphysema, tuberculosis sequelae, prior lung surgery 2. Obstructive ventilatory disorder 3. Counterindication to pulmonary function testing 4. Women : Pregnancy or milking 5. Lack of health insurance Controls : INCLUSION CRITERIA 1. Volunteers aged 18-85 years, free of any respiratory disease 2. Volunteer gave informed consent Secondary

Exclusion criteria

Abnormal PFT : Total lung capacity or FEV1/VC ratio \< Lower Limit of Normal Non-IPF ILD : INCLUSION CRITERIA 1. Age 18-85 years 2. Radiological interstitial pneumonia, on 2 tests performed \>3 months apart 3. PINS histology OR sarcoidosis histology OR clinical diagnosis of drug-induced lung disease OR diagnosis of auto-immune disease 4. Patient gave informed consent NON INCLUSION CRITERIA 1. Presence of respiratory comorbidities : Asthma, COPD, bronchiectasis, emphysema, tuberculosis sequelae, prior lung surgery 2. Obstructive ventilatory disorder 3. Counterindication to pulmonary function testing 4. Women : Pregnancy or milking 5. Lack of health insurance Uncharacterized ILD : INCLUSION CRITERIA 1. Age 18-85 years 2. Radiological interstitial pneumonia, on 2 tests performed \>3 months apart 3. Patient gave informed consent NON INCLUSION CRITERIA 1. Presence of respiratory comorbidities : Asthma, COPD, bronchiectasis, emphysema, tuberculosis sequelae, prior lung surgery 2. Obstructive ventilatory disorder 3. Counterindication to pulmonary function testing 4. Women : Pregnancy or milking 5. Lack of health insurance Secondary

Design outcomes

Primary

MeasureTime frameDescription
Fowler dead space1 dayConducting airway volume is determined by Fowler's method from volumetric capnography data

Secondary

MeasureTime frameDescription
Bohr anatomic dead space1 dayBohr anatomic dead space is determined from capnography and spirometry data.

Countries

France

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026